NCT06831162

Brief Summary

The goal of this study is to evaluate the effectiveness of a multi-level health-related social needs (HRSN) initiative among adult patients diagnosed with type 2 diabetes, plus hypertension or hyperlipidemia. The multi-level initiative includes HRSN data collection, training and tools for health care professionals, care coordinator support, and community resources. Patients with type 2 diabetes plus hypertension or hyperlipidemia will be screened for HRSN as part of the primary care clinic intake process to assess if patients have any social needs (like difficulty with getting food, housing, or transportation). If patients screen positive for having social needs, then patients will be offered support, which can include help from primary care providers with adjusting a patient's disease management plan, referrals to care coordinators to provide additional assistance in addressing social needs, and information about community organizations that offer resources for social needs. The initiative will be integrated as a system change across VUMC adult primary care practices. The investigators will use a prospective, single-arm clinical trial to evaluate effects on clinical outcomes for 12 months. Data will be extracted from the EHR on adult patients diagnosed with type 2 diabetes, and either hypertension or hyperlipidemia. The investigators hypothesize that the initiative will reduce the impact of HRSN on clinical outcomes over the study period. The investigators will also administer surveys to a subgroup of patients to examine trends in self-reported psychosocial and behavioral measures over the course of the initiative.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,809

participants targeted

Target at P75+ for not_applicable type-2-diabetes

Timeline
4mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
Jan 2025Sep 2026

Study Start

First participant enrolled

January 24, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

February 13, 2025

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 17, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2026

Last Updated

March 11, 2026

Status Verified

March 1, 2026

Enrollment Period

1.6 years

First QC Date

February 13, 2025

Last Update Submit

March 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in glycemic control

    Hemoglobin A1c extracted from the electronic health record where higher values indicate worse glycemic control.

    Baseline and 12 months post-baseline

Secondary Outcomes (2)

  • Change in cholesterol

    Baseline and 12 months post-baseline

  • Change in blood pressure

    Baseline and 12 months post-baseline

Other Outcomes (8)

  • Change in medication adherence (survey)

    Baseline and 6 months post-baseline

  • Change in dietary behavior (survey)

    Baseline and 6 months post-baseline

  • Change in dietary behavior (survey)

    Baseline and 6 months post-baseline

  • +5 more other outcomes

Study Arms (1)

Multi-level HRSN initiative

EXPERIMENTAL

Eligible patients will receive the HRSN initiative as part of their primary care appointments

Other: Multi-level HRSN initiative

Interventions

The multi-level health-related social needs (HRSN) initiative includes multiple components aimed at assessing and addressing HRSN in clinical practice: HRSN screening, EHR tools for clinical decision support, training and tools for health care providers to address HRSN, care coordinator support for patient outreach, and community resources for referral and support.

Multi-level HRSN initiative

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Completed the health-related social needs (HRSN) screener as part of a primary care visit
  • Diagnosed with type 2 diabetes, plus hypertension and/or hyperlipidemia as reflected by ICD-10 billing codes
  • Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
  • ELIGIBILITY CRITERIA FOR PATIENT SURVEYS (subset of EHR data)
  • years of age or older
  • Completed the HRSN screener as part of a primary care visit
  • Diagnosed with type 2 diabetes
  • Receive care at one of six partner Vanderbilt University Medical Center primary care clinics: South One Hundred Oaks, North One Hundred Oaks, Green Hills, Hillsboro Medical Group, Melrose, Bellevue
  • English-speaking

You may not qualify if:

  • Blindness
  • Hearing impairment
  • Conditions that would interfere with survey completion (e.g., significant dementia, active psychosis or mania)
  • Being near the end of life (hospice or home hospice)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt University Medical Center

Nashville, Tennessee, 37203, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2HypertensionHyperlipidemias

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesVascular DiseasesCardiovascular DiseasesDyslipidemiasLipid Metabolism Disorders

Study Officials

  • Sunil Kripalani, MD, MSc

    Vanderbilt University Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 13, 2025

First Posted

February 17, 2025

Study Start

January 24, 2025

Primary Completion (Estimated)

September 4, 2026

Study Completion (Estimated)

September 4, 2026

Last Updated

March 11, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

After study results are posted on clinical trials and published, de-identified data will be available upon requests made to the principal investigator.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
After study results are posted on clinical trials and outcomes published in a peer-reviewed journal, until 5 years later
Access Criteria
Contact the principal investigator

Locations